Takako Yokomizo-Nakano

8PUBLICATIONS
40CO-AUTHORS
Regenerative medicine (incl. stem cells)Infant and child healthEpigenetics (incl. genome methylation and epigenomics)Haematological tumoursMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 22, 2026
Niche-targeted therapy via YAP/TAZ activation enhances hematopoietic regeneration.

|Apr 08, 2026
Polycomb repressive complex 2 insufficiency underlies myeloid leukemia in Down syndrome.

Yutaro Suzuki, Yaeko Nakajima-Takagi, Motohiko Oshima

|May 29, 2024
Chromatin modifier Hmga2 promotes adult hematopoietic stem cell function and blood regeneration in stress conditions.

Sho Kubota, Yuqi Sun, Mariko Morii

|May 11, 2024
TIF1β activates leukemic transcriptional program in HSCs and promotes BCR::ABL1-induced myeloid leukemia.

Mariko Morii, Sho Kubota, Mihoko Iimori

|Apr 18, 2023
Exposure to microbial products followed by loss of Tet2 promotes myelodysplastic syndrome via remodeling HSCs.

Takako Yokomizo-Nakano, Ai Hamashima, Sho Kubota

|May 31, 2022
HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner.

Supannika Sorin, Sho Kubota, Sofiane Hamidi

Pageof 2

Frequent Collaborators

6 joint publications

Sho Kubota

6 joint publications

Goro Sashida

3 joint publications

Mariko Morii

3 joint publications

Atsushi Iwama